LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Reactive Pneumocytes Identified by Distinctive Cytology

By LabMedica International staff writers
Posted on 15 Apr 2020
Print article
Image: Touch preparation smears from cases of various forms of lung injury with reactive pneumocytes, illustrating markedly enlarged and highly atypical epithelial cells retaining distinctive Napoleon hat–like shapes (Photo courtesy of Natasha Rekhtman, MD, PhD).
Image: Touch preparation smears from cases of various forms of lung injury with reactive pneumocytes, illustrating markedly enlarged and highly atypical epithelial cells retaining distinctive Napoleon hat–like shapes (Photo courtesy of Natasha Rekhtman, MD, PhD).
One of the most challenging and exceedingly common diagnostic dilemmas in pulmonary pathology is the distinction between reactive and neoplastic epithelial atypia. In particular, reactive pneumocytes in various infectious or inflammatory lung diseases can exhibit marked cytological atypia, which can closely resemble malignancy.

Various types of acute and subacute lung injury can cause severe reactive pneumocyte atypia, which may mimic malignant proliferations and present a major diagnostic pitfall. This particularly applies to cytological preparations and frozen sections, where background inflammatory injury may be subtle or not apparent.

A pathologist at the Memorial Sloan Kettering Cancer Center (New York, NY, USA) has written that the most severe reactive pneumocyte atypia occurs in florid diffuse alveolar damage, where in the organizing phase, hyaline membranes are associated with markedly atypical pneumocytes. Key morphologic features of reactive pneumocytes in acute/subacute lung injury include marked cytomegaly, prominent nucleoli, and chromatin irregularities (clumping or clearing). Macronucleoli, of the type seen in melanomas or viral cytopathic effects, can be present. Nuclear contours may become focally irregular, but tend to remain smooth. Overdiagnosis of reactive pneumocytes as in adenocarcinoma is well documented in the literature. Some reactive pneumocytes have dense cytoplasm, which may also mimic squamous cell carcinoma.

Of particular note was one under recognized but extremely helpful cytomorphological clue to reactive pneumocytes in acute/subacute lung injuries is their highly distinctive shape, characterized by an elongated/pinched outline with a flat surface on one side and a convex surface with protruding nucleus on the opposite side. The flat surface corresponds to the area where the pneumocytes are plastered against the alveolar wall, whereas the convex surface corresponds to the area protruding into the airspaces. Even though the relationship of reactive pneumocytes to alveolar walls is usually not evident in dispersed cytological preparations or may be obscured in frozen sections and some small biopsies, this distinctive shape of reactive pneumocytes tends to be preserved in such specimens.

This shape evokes the look of Napoleon Bonaparte's iconic headwear; the bicorne (2-cornered) hat, thus prompting the proposed term of a “Napoleon hat” sign. Unlike reactive proliferations, the Napoleon hat shapes are only rarely encountered in carcinomas. Although lepidic adenocarcinomas do feature rows of neoplastic pneumocytes growing along alveolar walls, those cells characteristically have cuboidal/hobnail rather than elongated/pinched shapes.

Notably, Napoleon hat shapes tend to be well preserved in direct smears from fine-needle aspirates and touch preparations of core biopsies, whereas in bronchioloalveolar lavage fluids, cells tend to get rounded off, and this feature appears to be more subtle, but still evident in some cells. In frozen section and small biopsies, Napoleon hat shapes may also provide a useful clue to a reactive nature of epithelial atypia. The study was published in the April 2020 issue of the journal Archives of Pathology & Laboratory Medicine.

Related Links:
Memorial Sloan Kettering Cancer Center

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.